Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 20 de 45
Filter
1.
Eur J Pediatr ; 180(2): 461-468, 2021 Feb.
Article in English | MEDLINE | ID: mdl-33083899

ABSTRACT

The aim of this study was to compare the skeletal muscle thickness of three different muscles and muscle groups in 44 preterm infants studied at term-equivalent age and 44 full-term controls: the biceps brachii, quadriceps femoris, and anterior tibial. The study was carried out at the Careggi University Hospital, Florence, Italy, from January 2018 to December 2019. We assumed that impaired muscle thickness in premature infants would be correlated with exposure to risk factors in the postnatal period. When the premature babies reached term-equivalent age, they were statistically significantly thinner and shorter and had a lower head circumference and lower body mass index than the full-term controls. The muscle thicknesses in the proximal and distal districts were statistically significantly smaller in prematurely born than term-born infants. The skeletal muscle thickness was related to the revised Clinical Risk Index for Babies score and days of invasive mechanical ventilation.Conclusion: Our data show that at term-equivalent age the premature babies had lower skeletal muscle mass acquisition than the full-term controls. This was particularly due to critical conditions at birth and the subsequent duration of invasive mechanical ventilation. What is Known: • The deleterious effects of prolonged mechanical ventilation on skeletal muscle function have been reported by adult intensive care studies. • Ultrasound imagines of fat and muscle thickness have been used in neonatology, as the method is safe, portable, and noninvasive. What is New: • Premature babies studied at term-equivalent age had lower muscle acquisition, but similar subcutaneous fat thickness, to full-term controls. • A high revised Clinical Risk Index for Babies score at birth, and prolonged invasive mechanical ventilation, was associated with skeletal muscle impairment.


Subject(s)
Infant, Premature, Diseases , Infant, Premature , Adult , Gestational Age , Humans , Infant , Infant, Low Birth Weight , Infant, Newborn , Italy , Ultrasonography
2.
Biol Psychiatry ; 88(7): 531-540, 2020 10 01.
Article in English | MEDLINE | ID: mdl-32912426

ABSTRACT

The stress response is an adaptive means of maintaining physiological homeostasis in the face of changing environmental conditions. However, protracted recruitment of stress systems can precipitate wear and tear on the body and may lead to many forms of disease. The mechanisms underlying the connection between chronic stress and disease are not fully understood and are likely multifactorial. In this review, we evaluate the possibility that the hormone ghrelin may contribute to the pathophysiology that follows chronic stress. Since ghrelin was discovered as a pro-hunger hormone, many additional roles for it have been identified, including in learning, memory, reward, and stress. We describe the beneficial effects that ghrelin exerts in healthy mammals and discuss that prolonged exposure to ghrelin has been linked to maladaptive responses and behaviors in the realm of psychiatric disease. In addition, we consider whether chronic stress-associated altered ghrelin signaling may enhance susceptibility to posttraumatic stress disorder and comorbid conditions such as major depressive disorder and alcohol use disorder. Finally, we explore the possibility that ghrelin-based therapeutics could eventually form the basis of a treatment strategy for illnesses that are linked to chronic stress and potentially also ghrelin dysregulation, and we identify critical avenues for future research in this regard.


Subject(s)
Depressive Disorder, Major , Stress Disorders, Post-Traumatic , Animals , Ghrelin , Memory , Reward
3.
Acta Paediatr ; 108(7): 1256-1261, 2019 07.
Article in English | MEDLINE | ID: mdl-30788864

ABSTRACT

AIM: We examined associations between neurological alterations in infants born to smoking mothers and breastfeeding success at discharge and three months of age. METHODS: This 2016 study compared 35 normal weight infants born to smoking mothers at 37-41 weeks and 35 matched controls born to non-smoking mothers at the Maternity Hospital of Careggi University, Florence, Italy. Neonatal behaviour was evaluated using the neurological soft signs (NSS) component of the Graham-Rosenblith Scale. Breastfeeding variables were measured using the LATCH score that covers: breast latching, audible swallowing, type of nipple, mother's comfort and help they needed to hold their baby to their breast. A questionnaire on excessive crying and feeding was distributed at discharge, and further data were collected during a three-month telephone interview. RESULTS: At discharge, the infants born to smoking mothers had a significantly lower LATCH score and significantly poorer performance on several items of the NSS component than the controls. The LATCH score and number of NSS were inversely proportional. At the three-month follow-up only 57.1% of the smoking group infants were breastfeeding compared with 87.5% of the control infants (p < 0.01). CONCLUSION: Infants with smoking mothers displayed altered neurobehavioural profiles and had a difficult start to breastfeeding.


Subject(s)
Breast Feeding/statistics & numerical data , Infant Behavior/drug effects , Prenatal Exposure Delayed Effects , Smoking/adverse effects , Case-Control Studies , Female , Humans , Infant, Newborn , Male , Pregnancy
4.
Transl Psychiatry ; 8(1): 74, 2018 04 11.
Article in English | MEDLINE | ID: mdl-29643360

ABSTRACT

Prolonged stressor exposure in adolescence enhances the risk of developing stress-sensitive mental illnesses, including posttraumatic stress disorder (PTSD), for many years following exposure cessation, but the biological underpinnings of this long-term vulnerability are unknown. We show that severe stressor exposure increased circulating levels of the hormone acyl-ghrelin in adolescent rats for at least 130 days and in adolescent humans for at least 4.5 years. Using a rodent model of longitudinal PTSD vulnerability in which rodents with a history of stressor exposure during adolescence display enhanced fear in response to fear conditioning administered weeks after stressor exposure ends, we show that systemic delivery of a ghrelin receptor antagonist for 4 weeks surrounding stressor exposure (2 weeks during and 2 weeks following) prevented stress-enhanced fear memory. These data suggest that protracted exposure to elevated acyl-ghrelin levels mediates a persistent vulnerability to stress-enhanced fear after stressor exposure ends.


Subject(s)
Ghrelin/blood , Stress, Psychological/blood , Adolescent , Animals , Biomarkers/blood , Chronic Disease , Conditioning, Classical , Disease Models, Animal , Fear , Female , Humans , Male , Rats, Long-Evans , Restraint, Physical , Stress Disorders, Post-Traumatic/blood
5.
Con-ciencia (La Paz) ; 5(2): 81-95, nov. 2017. ilus., tab.
Article in Spanish | LILACS | ID: biblio-1178836

ABSTRACT

El presente es un estudio de tipo descriptivo no experimental para determinar sangre oculta de heces (SOH) en población aparentemente sana. La presencia de SOH, puede estar relacionada con varias causas, como gastritis, úlcera péptica o duodenal, parasitosis intestinal, sangrado de encías o cáncer colorectal. Se analizaron 1093 muestras de heces fecales provenientes de estudiantes que cursaban la cátedra de Anatomía y Fisiología de la FCFB de la UMSA y su entorno familiar. Utilizando el método inmunocromatográfico (SUMASOHF), todos los investigadores que participaron fueron capacitados para realizar el análisis. Las muestras se procesaron, por duplicado y aquellas que dieron resultado positivo, se procesaron nuevamente. Los resultados se analizaron con el programa estadístico SPSS 22. Se encontró presencia de SOH en el 16,1% de todas las muestras procesadas. El porcentaje de casos positivos de SOH fue ligeramente superior en el género masculino y en el grupo etario de 61-80 años. En el grupo de fumadores se reveló un 24.50% de casos positivos y un 19.20% en las personas que declararon consumir bebidas alcohólicas. También se consideraron otras causas de SOH, como la insuficiencia cardiaca, la gastritis, la ingestión de medicamentos como la aspirina y el ibuprofeno. A todos los casos que dieron positivo de SOH, se recomendó consultar con su médico para realizar otros exámenes más específicos. En conclusión la pérdida de sangre por heces fecales es un problema, que puede pasar desapercibido por la ausencia de sintomatología; por lo tanto, sugerimos que esta prueba sea incluida en la evaluación rutinaria de pacientes.


A descriptive, non-experimental study was carried out to determine the presence of fecal occult blood (SOH) considering its relation with the early diagnosis of colorectal cancer. We analyzed 1093 fecal samples from students who were in the Chair of Anatomy and Physiology of the FCFB of UMSA and their family environment. Using the immunochromatographic method (SUMASOHF), all the researchers who participated were trained to perform the analysis. The samples were processed in the laboratory of Anatomy and Physiology, using a inmunocromatographic metod, (SUMASOHF). The investigatours were trained to perform the test and the samples were processed with the supervision of the professors. All samples were processed in duplicate and all positive samples were reprocessed. All results were registrated in the correspondy datasheet. The data were analysed using the a statistical program SPSS 22. We found presence of fecal occult blood in 16.1 % of the samples. The percentage of positive cases of SOH in the male gender was slightly higher compared to the number of positive cases was higher in goner of 61 to 80 age group. In the group of smokers revealed a 24.50% of positive cases and 19.20% in the group that consumes alcohol. Other causes of SOH were also investigated such as heart failure, gastritis, ingestion of drugs such as aspirin and ibuprofen. In some cases, no probable cause of bleeding was found. It was recommended to all participant with a positive test, consult their doctors for more specific diagnosis. Here were concluded that stool blood loss is a problem, which is ignored since there is absence of symptomatology, therefore, we suggest that this test be included in the routine evaluation of patients.


Subject(s)
Parasitic Diseases , Occult Blood , Patients , Peptic Ulcer , Ibuprofen , Feces , Smokers , Gastritis
6.
Biol Psychiatry ; 81(12): 1003-1013, 2017 06 15.
Article in English | MEDLINE | ID: mdl-28010876

ABSTRACT

BACKGROUND: There are many contradictory findings about the role of the hormone ghrelin in aversive processing, with studies suggesting that ghrelin signaling can both inhibit and enhance aversion. Here, we characterize and reconcile the paradoxical role of ghrelin in the acquisition of fearful memories. METHODS: We used enzyme-linked immunosorbent assay to measure endogenous acyl-ghrelin and corticosterone at time points surrounding auditory fear learning. We used pharmacological (systemic and intra-amygdala) manipulations of ghrelin signaling and examined several aversive and appetitive behaviors. We also used biotin-labeled ghrelin to visualize ghrelin binding sites in coronal brain sections of amygdala. All work was performed in rats. RESULTS: In unstressed rodents, endogenous peripheral acyl-ghrelin robustly inhibits fear memory consolidation through actions in the amygdala and accounts for virtually all interindividual variability in long-term fear memory strength. Higher levels of endogenous ghrelin after fear learning were associated with weaker long-term fear memories, and pharmacological agonism of the ghrelin receptor during the memory consolidation period reduced fear memory strength. These fear-inhibitory effects cannot be explained by changes in appetitive behavior. In contrast, we show that chronic stress, which increases both circulating endogenous acyl-ghrelin and fear memory formation, promotes profound loss of ghrelin binding sites in the amygdala and behavioral insensitivity to ghrelin receptor agonism. CONCLUSIONS: These studies provide a new link between stress, a novel type of metabolic resistance, and vulnerability to excessive fear memory formation and reveal that ghrelin can regulate negative emotionality in unstressed animals without altering appetite.


Subject(s)
Amygdala/metabolism , Fear/physiology , Ghrelin/physiology , Memory Consolidation/physiology , Memory/physiology , Amygdala/drug effects , Animals , Conditioning, Classical/physiology , Corticosterone/blood , Eating/physiology , Fear/drug effects , Ghrelin/blood , Indoles/pharmacology , Male , Memory/drug effects , Rats , Receptors, Ghrelin/agonists , Receptors, Ghrelin/antagonists & inhibitors , Receptors, Ghrelin/metabolism , Spiro Compounds/pharmacology , Stress, Psychological/metabolism
7.
Enferm. glob ; 14(37): 435-444, ene. 2015. tab, ilus
Article in Spanish | IBECS | ID: ibc-131085

ABSTRACT

Objetivo: Evaluar la evidencia disponible sobre la efectividad de las intervenciones que han utilizado mensajes de texto para la disminución de los niveles de hemoglobina glucosilada en el control glucémico en personas con DT2 Métodos: Se realizó una revisión sistemática en las bases de datos MEDLINE, Elsevier, Springer, DARE, CINAHL, Scopus, y Open Access, se identificaron ocho artículos que cumplieron con los criterios de elegibilidad para evaluar el uso de los mensajes de texto y los niveles de HbA1c. Resultados: El envío de mensajes de texto a través de teléfono móvil mostró una disminución de los niveles de hemoglobina glucosilada en pacientes adultos con DT2 Conclusiones: La utilización de mensajes de texto en la atención de los pacientes con DT2, se presenta como una tecnología factible y bien aceptada sin embargo los estudios señalaron que la evidencia aún no es concluyente en la mejoría del control glucémico (AU)


Objective: The aim of this systematic review was to evaluate the effectiveness interventions that have used text messaging in the reduction of glycosylated hemoglobin levels in type 2 diabetes patients. Methods: a systematic review of articles published in the MEDLINE database, Elsevier, Springer, DARE, CINAHL, Scopus, and Open Access, eight interventions studies that met the inclusion criteria, Results: Intervention using short message services of cellular phones improved HbA1c levels and improved the metabolic control in T2D adults. Conclusions: The use of text messaging in the management of T2D, is presented as a suitable, practical, and well accepted technology, it has strong potential for providing effective, ongoing support in the future. However the research studies, showed that the evidence is not yet conclusive to the improvement in glycemic control (AU)


Subject(s)
Humans , Male , Female , Adult , Blood Glucose/analysis , Blood Glucose Self-Monitoring/instrumentation , Blood Glucose Self-Monitoring/methods , Blood Glucose Self-Monitoring , Text Messaging/instrumentation , Text Messaging , Diabetes Mellitus, Type 2/epidemiology , Diabetes Mellitus, Type 2/prevention & control , Blood Glucose/physiology , Blood Glucose Self-Monitoring/economics , Blood Glucose Self-Monitoring/trends , Glycemic Index/physiology , Text Messaging/statistics & numerical data , Text Messaging/standards , Text Messaging/trends
8.
Phys Rev Lett ; 109(4): 041101, 2012 Jul 27.
Article in English | MEDLINE | ID: mdl-23006072

ABSTRACT

Using high-resolution microwave sky maps made by the Atacama Cosmology Telescope, we for the first time present strong evidence for motions of galaxy clusters and groups via microwave background temperature distortions due to the kinematic Sunyaev-Zel'dovich effect. Galaxy clusters are identified by their constituent luminous galaxies observed by the Baryon Oscillation Spectroscopic Survey, part of the Sloan Digital Sky Survey III. We measure the mean pairwise momentum of clusters, with a probability of the signal being due to random errors of 0.002, and the signal is consistent with the growth of cosmic structure in the standard model of cosmology.

9.
Liver Transpl ; 14(5): 684-7, 2008 May.
Article in English | MEDLINE | ID: mdl-18433037

ABSTRACT

Acute hypotensive transfusion reactions are newly characterized transfusion reactions in which hypotension is the prominent feature. The pathophysiology of acute hypotensive transfusion reactions is related to the bradykinin function and its metabolism. A liver transplant recipient on treatment with an angiotensin converting enzyme inhibitor developed sudden hypotension, that is, systolic pressure of 60 mm Hg, after receiving 200 mL of a blood product mixture without significant surgical blood loss. He responded to the resuscitation measure, although hypotension developed again after a challenge transfusion of 200 mL of the blood mixture. A severe hypotensive reaction to the blood transfusion and diffuse bleeding from the dissection surfaces forced the transplantation to be aborted after the common bile duct had been divided. We hypothesized that the patient had an acute hypotensive transfusion reaction due to disordered bradykinin metabolism. Analysis of his blood showed low levels of both angiotensin converting enzyme and aminopeptidase P enzyme activity, confirming that the patient experienced an acute hypotensive transfusion reaction that was due to the use of the angiotensin converting enzyme inhibitor and was precipitated by an abnormality in the metabolic enzyme pathway. It is recommended to discontinue angiotensin converting enzyme inhibitors and switch to a different class of antihypertensive medications for patients with a high Model for End-Stage Liver Disease score on the waiting list for liver transplantation.


Subject(s)
Aminopeptidases/blood , Angiotensin-Converting Enzyme Inhibitors/adverse effects , Antihypertensive Agents/adverse effects , Hypotension/etiology , Liver Failure/surgery , Liver Transplantation , Transfusion Reaction , Acute Disease , Blood Pressure , Down-Regulation , Fatal Outcome , Humans , Hypotension/chemically induced , Hypotension/enzymology , Hypotension/physiopathology , Liver Failure/enzymology , Male , Middle Aged , Reoperation , Treatment Failure
10.
Eur Respir J ; 23(2): 275-80, 2004 Feb.
Article in English | MEDLINE | ID: mdl-14979503

ABSTRACT

This study aims at evaluating the effects of lung volume reduction versus respiratory rehabilitation on quality of life, assessed by three different questionnaires. Sixty emphysematous patients were randomised by computer to receive either surgery (n = 30) or rehabilitation (n = 30). Life quality was evaluated by the Nottingham Health Profile, the Short Form (SF)-36 item and the St George's questionnaires. As reported previously, dyspnoea index, forced expiratory volume in one second, residual volume, 6-min walk test and arterial oxygen tension improved after surgery more than after rehabilitation. Quality of life was significantly improved after surgery as follows Nottingham Health Profile physical mobility; SF-36 physical and social functioning, mental and general health, emotional role; St George's general, activity. At multivariate analysis 6- and 12-month changes after surgery of Short Form-36 physical functioning, general health, and St George's activity domains were significantly correlated with forced expiratory volume in one second, while Short Form-36 social functioning and Nottingham Health Profile isolation correlated with residual volume. Functional and especially symptomatic improvements persisted: dyspnoea index, residual volume, and Short Form-36 and St Georges's physical scores were still significant at 4 yrs. Surgery produces greater and longer effects than rehabilitation on quality of life by improving both physical and psychosocial domains. Symptomatic improvements persisted at 4 yrs.


Subject(s)
Breathing Exercises , Exercise Therapy , Pneumonectomy , Pulmonary Emphysema/rehabilitation , Pulmonary Emphysema/surgery , Quality of Life , Thoracic Surgery, Video-Assisted , Activities of Daily Living/classification , Activities of Daily Living/psychology , Aged , Dyspnea/etiology , Dyspnea/psychology , Female , Follow-Up Studies , Humans , Male , Middle Aged , Outcome and Process Assessment, Health Care , Patient Education as Topic , Patient Satisfaction , Pneumonectomy/psychology , Postoperative Complications/etiology , Postoperative Complications/psychology , Pulmonary Emphysema/psychology , Quality of Life/psychology , Respiratory Function Tests , Rome
11.
HIV Med ; 3(1): 62-4, 2002 Jan.
Article in English | MEDLINE | ID: mdl-12059953

ABSTRACT

We evaluated adherence to HIV treatments every 4 months during one year in 63 HIV-infected subjects using combination therapies including a protease inhibitor. A total of 18 subjects reported a high level of adherence, 14 in two evaluations, and eight a low level of adherence in all the three evaluations. The remaining 23 subjects (36.5%) reported different levels of adherence to treatment in the three evaluations. These findings suggest that the level of adherence to treatment changes markedly for each patient over time.


Subject(s)
HIV Infections/drug therapy , HIV Protease Inhibitors/therapeutic use , Patient Compliance , Adolescent , Adult , CD4-Positive T-Lymphocytes , Cross-Sectional Studies , Drug Therapy, Combination , Female , Follow-Up Studies , HIV Infections/psychology , Humans , Lymphocyte Count , Male , Surveys and Questionnaires , Viral Load
14.
J Clin Pharmacol ; 41(10): 1075-81, 2001 Oct.
Article in English | MEDLINE | ID: mdl-11583475

ABSTRACT

This study evaluates the effects of early administration of dexamethasone on left ventricle dimensions and their clinical significance in preterm infants. Fifty preterm infants with birth weight < or = 1250 g and gestational age < or = 30 weeks were randomly assigned after 72 hours of life to the dexamethasone group (n = 25) or to the control group (n = 25). The treated infants received dexamethasone intravenously from the 4th day of life for 7 days (0.5 mg/kg/day for the first 3 days, 0.25 mg/kg/day for the next 3 days, and 0.125 mg/kg/day for the 7th day). Serial echocardiographic measurements of end systolic interventricular septum thickness, end diastolic interventricular septum thickness, end systolic left ventricle posterior wall thickness, end diastolic left ventricle posterior wall thickness, left ventricle end diastolic diameter, and left ventricle end systolic diameter were taken before starting dexamethasone, on days 3 and 7 of treatment, 7 days after the interruption of treatment, and at the 28th day of life. Five infants of each group were excluded by the final analysis because of the lack of a complete cardiac evaluation, leaving 20 treated and 20 control infants. Infants receiving dexamethasone had a significantly larger increase in mean septal and left posterior wall thickness during the treatment and 7 days after the dexamethasone weaning. The mean left ventricle diameter of treated infants was significantly lower than that of control infants from the 7th day of treatment to the 28th day of life. Four neonates (20%) in the dexamethasone group developed left ventricular myocardial hypertrophy without left ventricle outflow tract obstruction, showing signs of decreased cardiac output and ischemic changes on ECG. The daily fluid intake was increased to 200 ml/kg to ensure an adequate preload volume, and the complete resolution of left ventricle hypertrophy was obtained within the 2nd to 3rd week after dexamethasone weaning. Preterm infants receiving an early (< 96 hours of life) short course of dexamethasone develop a left ventricular myocardial hypertrophy that can be symptomatic and clinically significant. Preterm infants included in future studies with the goal to find the minimum dose and duration of dexamethasone treatment should be strictly monitored echocardiographically for this side effect.


Subject(s)
Anti-Inflammatory Agents/adverse effects , Cardiovascular System/drug effects , Dexamethasone/adverse effects , Infant, Premature , Anti-Inflammatory Agents/therapeutic use , Cardiovascular System/physiopathology , Dexamethasone/therapeutic use , Drug Administration Schedule , Female , Humans , Hypertrophy, Left Ventricular/chemically induced , Hypertrophy, Left Ventricular/diagnostic imaging , Infant, Newborn , Infant, Premature/physiology , Lung Diseases/prevention & control , Male , Prospective Studies , Respiratory Distress Syndrome, Newborn/drug therapy , Ultrasonography , Ventricular Function, Left/drug effects , Ventricular Function, Left/physiology
15.
Eur J Cardiothorac Surg ; 20(2): 356-60, 2001 Aug.
Article in English | MEDLINE | ID: mdl-11463557

ABSTRACT

OBJECTIVE: To retrospectively assess the results of surgical treatment in a consecutive series of 110 patients with Stage IIb and IIIa non small cell lung cancer (NSCLC) invading chest wall. METHODS: A series of 110 patients underwent surgery for Stage IIb and IIIa NSCLC with involvement of chest wall. There were 101 male and 9 female patients, mean age was 61.4 (range 32--74), 52 (47.3%) of them complaining for chest pain. Surgical procedures were pneumonectomy in seven patients (6.4%), lobectomy in 73 (66.4%), bi-lobectomy in six (5.4%) and wedge resection in 24 (21.8%). In 63 patients (57.3%) an extrapleural resection was performed while in the other 47 (42.7%) an 'en bloc' resection of tumor with chest wall was required. In 22 patients (76.3%) repair was achieved by muscle flap while in 8 (26.7%) a prosthesis was required. Five-year survival was computed using the Kaplan--Meier method; P values correspond to the log-rank test. RESULTS: There were neither intraoperative nor postoperative deaths. Postoperative staging revealed 83 T3N0M0, 17 T3N1M0 and 10 T3N2M0. Mean postoperative hospital stay was 17.7 days (range 5--40). For N0 patients 5 year survival was 47% (39/83) and no significant difference was noted when extrapleural and 'en bloc' resection groups were compared (P = 0.08). In N1/N2 patients no survival was observed (0/27) and comparison between surgical procedures was not statistically significant (P = 0.41). Moreover when N0 patients were compared with N1 patients the difference in survival was significant for both extrapleural (P = 0.02) and 'en bloc' (P = 0.04) groups. No difference was noted when the two surgical procedures were compared independently form N status (P = 0.94). Within the group of patients undergone 'en bloc' resection survival was significantly better for N0 patients as in the group of extrapleural resection. CONCLUSION: Surgical treatment of Stage IIb and IIIa NSCLC invading chest wall by extrapleural or 'en bloc' resection is widely adopted and justified by the good results in terms of morbidity and relief of pain. Survival is always depending on the N status.


Subject(s)
Carcinoma, Non-Small-Cell Lung/pathology , Carcinoma, Non-Small-Cell Lung/surgery , Lung Neoplasms/pathology , Lung Neoplasms/surgery , Adult , Aged , Carcinoma, Non-Small-Cell Lung/mortality , Female , Humans , Lung Neoplasms/mortality , Male , Middle Aged , Neoplasm Invasiveness , Retrospective Studies
16.
Eur J Epidemiol ; 17(4): 317-21, 2001.
Article in English | MEDLINE | ID: mdl-11767956

ABSTRACT

Since 1990 a clone of gentamicin and methicillin-resistant Staphylococcus aureus (MRSA) has remained endemic in our hospital, but since January 1996 a gentamicin-sensitive strain has progressively replaced the previous clone. We characterized the phenotypic and molecular pattern of the MRSA strains isolated in our hospital in 1996 and compared prospectively the epidemiological, clinical and evolutionary characteristics of ninety patients infected or colonized by gentamicin-sensitive MRSA (GS-MRSA) (49) and by gentamicin-resistant MRSA (GR-MRSA) (41). Finally we studied the variation of aminoglycoside consumption in our hospital from 1989 to 1996. We observed two antibiotypes (GS-MRSA and GR-MRSA) corresponding to two major chromosomal patterns. Patients with GS-MRSA usually acquired the infection 72 hours after hospital admission. No significant differences were observed in epidemiological characteristics, clinical presentation and evolution between patients with GS-MRSA and GR-MRSA. Since 1989 aminoglycoside intake in our hospital has decreased by 46%.


Subject(s)
Anti-Bacterial Agents/therapeutic use , Gentamicins/therapeutic use , Hospitals , Methicillin Resistance , Staphylococcal Infections/drug therapy , Staphylococcal Infections/epidemiology , Staphylococcus aureus/drug effects , Staphylococcus aureus/pathogenicity , Adolescent , Adult , Aged , Aged, 80 and over , Endemic Diseases , Female , Humans , Male , Middle Aged , Phenotype , Prospective Studies , Spain/epidemiology
17.
Eur J Cardiothorac Surg ; 18(5): 524-8, 2000 Nov.
Article in English | MEDLINE | ID: mdl-11053811

ABSTRACT

OBJECTIVE: Having demonstrated a poor prognosis of operable lung cancer in patients with previous head and neck malignancies, we intended to evaluate prognosis of lung cancer in patients with a history of extrapulmonary and extracervical malignancies. METHODS: The population of this study included 55 patients; these were 40 males and 15 females, with a mean age 64.4+/-8.6 years. The previous malignancy was considered tobacco-induced in 15 patients (kidney, two; bladder, ten; esophagus, three), hormone-dependant in 18 (breast, six; female genital, eight; prostate, four), and miscellaneous in 22 (leukemia, four; skin, seven; colon, 11). Following complete resection, 25 patients were classified stage I, 13 were stage II, and 17 were stage IIIA. RESULTS: There were two early perioperative deaths (3.6%), and three during the second month owing to cardiovascular complications. At the conclusion of the study (July 1st, 1997), 32 further patients had died (58.2%): 25 had progression of lung cancer, one had progression of previous malignancy, and six were without evidence of disease. Five-year survival (Kaplan-Meier) was estimated 47+/-10.2% in stage I (median 44 months), 30.8+/-15.6% in stage II (median 26 months), and 16. 7+/-9.9% in stage IIIA (median 17 months). When excluding five early perioperative deaths, 5-year survival was 51.1+/-10.6% in stage I (median 93 months), 33.3+/-16.7% in stage II (median 36.5 months), and 19.0+/-11.2% in stage IIIA (median 20.5 months). Comparing the three groups defined according to location of previous malignancy, there was no significant difference neither in stage distribution (chi(2)=1.326; P=0.857), nor in 5-year survival estimates: 38.9+/-12. 9% (median 27 months) after tobacco-induced malignancies, 38.9+/-11. 5% (median 24 months) following hormone-dependant malignancies, and 28.4+/-10.2% (median 28 months) following miscellaneous cancers (chi(2)=0.059; P=0.9707). CONCLUSIONS: In opposition to data collected in patients with previous head and neck cancer, survival estimates according to stage were contained within the universally accepted range no high risk group has been identified. Resection of lung cancer with curative intent is a fair option in patients with previous extrapulmonary malignancy.


Subject(s)
Breast Neoplasms/pathology , Colonic Neoplasms/pathology , Endometrial Neoplasms/pathology , Lung Neoplasms , Pneumonectomy , Skin Neoplasms/pathology , Urinary Bladder Neoplasms/pathology , Adult , Aged , Aged, 80 and over , Esophageal Neoplasms/pathology , Female , Follow-Up Studies , Humans , Kidney Neoplasms/pathology , Lung Neoplasms/mortality , Lung Neoplasms/secondary , Lung Neoplasms/surgery , Male , Middle Aged , Neoplasm Staging , Patient Selection , Pneumonectomy/adverse effects , Pneumonectomy/mortality , Prognosis , Prostatic Neoplasms/pathology , Risk Factors , Smoking/adverse effects , Survival Analysis
18.
Lung Cancer ; 30(3): 203-10, 2000 Dec.
Article in English | MEDLINE | ID: mdl-11137206

ABSTRACT

Gemcitabine and paclitaxel are among the most active new agents in non-small cell lung cancer (NSCLC) and are worth considering for second-line chemotherapy. In this phase I-II study, we combined gemcitabine and paclitaxel for second-line treatment of advanced NSCLC. Gemcitabine doses were kept fixed at 1000 mg/m2 on day 1 and 8, and paclitaxel doses were escalated from 90 mg/m2 on day 1 of the 21-day cycle. Thirty-seven patients were treated at six different dose levels. Grade 4 neutropenia was dose-limiting toxicity (DLT), since it occurred in two out of six patients treated at paclitaxel 240 mg/m2; the paclitaxel dose level just below (210 mg/m2) was selected for phase Il evaluation. Non-hematologic toxicity was mild. One complete response (CR) (3%) and 13 partial responses (PR) (36%) were observed in 36 evaluable patients for an overall response rate of 39% (95% C.I., 23-57%). Median duration of response was 35 weeks (range, 8-102). All of the observed objective responses occurred in the 19 patients who had previously responded to the first-line therapy. Median survival was 40 weeks (range, 8-108 weeks). The combination of gemcitabine and paclitaxel is a feasible, well-tolerated, and active scheme for second-line treatment of advanced NSCLC; further evaluation, at least in selected patients, such as those previously responding to first-line chemotherapy, is definitely warranted.


Subject(s)
Antineoplastic Combined Chemotherapy Protocols/therapeutic use , Carcinoma, Non-Small-Cell Lung/drug therapy , Lung Neoplasms/drug therapy , Adult , Aged , Antineoplastic Combined Chemotherapy Protocols/adverse effects , Carcinoma, Non-Small-Cell Lung/pathology , Deoxycytidine/administration & dosage , Deoxycytidine/analogs & derivatives , Dose-Response Relationship, Drug , Female , Humans , Lung Neoplasms/pathology , Male , Middle Aged , Neutropenia/chemically induced , Paclitaxel/administration & dosage , Survival Analysis , Treatment Outcome , Gemcitabine
19.
Eur J Cardiothorac Surg ; 16(3): 276-82, 1999 Sep.
Article in English | MEDLINE | ID: mdl-10554843

ABSTRACT

BACKGROUND: This study was designed to determine whether bronchoplastic resection could be an alternative to pneumonectomy in patients with operable primary lung cancer. METHODS: From 1980 to 1996, 63 patients (59 males and four females; mean age 62 +/- 7 years) underwent a bronchoplastic lobectomy for non-small cell lung cancer, indicated because of a disabled respiratory function in 34 patients, and performed electively in 29 patients. There were 38 right upper lobectomies, four bilobectomies, one middle lobectomy combined with lower lobe apical segmentectomy, ten left upper and ten left lower lobectomies. The bronchoplasty was a full sleeve in 24 patients, and a bronchial wedge resection in 39. RESULTS: A single patient died post-operatively (1.6%). Specific procedure-related complications are summarized as follows: six anastomotic complications managed conservatively (9.5%), 15 space problems (23.8%), nine sputum retentions (14.2%). Pathologic staging classified 30 patients in stage I, 21 patients in stage II, and 12 in stage IIIA. Estimated 5-year survival was 69.7 +/- 9.8% in stage I, 37.1 +/- 12.1% in stage II, and 8.3 +/- 8.0% in stage IIIA. Fourteen patients (22.2%) developed locoregional recurrence. Three of them died with local recurrence alone, whereas 10 developed metastatic progression; a single patient is alive following completion pneumonectomy. According to stage, three recurrences occurred in stage I (10%), six in stage II (28%), and five in stage IIIA (38%). Actuarial freedom from local recurrence was significantly higher after elective procedures (P = 0.019); there was a trend towards improved outcome following right-sided procedures (P = 0.079) and following wedge bronchoplasty (P = 0.055). Five patients experienced a second primary cancer (7.9%), which was resected in four. CONCLUSION: Bronchoplastic resections achieve local control and long-term survival comparable to standard resections in patients with stage I or II disease, and may be considered as a valuable alternative to pneumonectomy.


Subject(s)
Carcinoma, Non-Small-Cell Lung/surgery , Lung Neoplasms/surgery , Neoplasm Recurrence, Local/mortality , Pneumonectomy/methods , Adult , Aged , Aged, 80 and over , Bronchi/surgery , Carcinoma, Non-Small-Cell Lung/diagnosis , Carcinoma, Non-Small-Cell Lung/mortality , Chi-Square Distribution , Female , Humans , Lung Neoplasms/diagnosis , Lung Neoplasms/mortality , Male , Middle Aged , Neoplasm Recurrence, Local/diagnosis , Pneumonectomy/mortality , Prognosis , Risk Assessment , Survival Analysis , Survival Rate
20.
Eur J Cardiothorac Surg ; 16(4): 414-7, 1999 Oct.
Article in English | MEDLINE | ID: mdl-10571087

ABSTRACT

OBJECTIVE: The prognostic factors and treatment options for thoracic aortic intramural hematoma are controversial. The purpose of this study was to determine the most suitable treatment of this condition in very elderly patients. METHODS: In a review of the world literature, eight octogenarians with thoracic aortic intramural hematoma were found; to these the three cases reported here must be added. The descending thoracic aorta was involved in eight cases and the ascending/arch in three. RESULTS: In spite of patients' poor general conditions, the medical treatment group showed survival rates of 85.7% (descending) and 66.6% (ascending/arch), respectively. CONCLUSION: Extensive atherosclerotic changes of the aortic wall in the elderly, combined with control of hypertension, may probably prevent thoracic aortic intramural hematoma from progressing to dissection, with a favourable outcome. An earlier and more accurate preoperative diagnosis by modern diagnostic techniques, including spiral computed tomography (CT), as were performed in our own patients, will allow optimal treatment and increased patient survival.


Subject(s)
Aortic Diseases/drug therapy , Hematoma/drug therapy , Nifedipine/therapeutic use , Vasodilator Agents/therapeutic use , Aged , Aged, 80 and over , Analgesics/therapeutic use , Aorta, Thoracic , Aortic Diseases/diagnostic imaging , Aortic Diseases/etiology , Aortography , Arteriosclerosis/complications , Drug Therapy, Combination , Female , Hematoma/diagnostic imaging , Hematoma/etiology , Humans , Hypertension/complications , Hypertension/drug therapy , Male , Nitroprusside/therapeutic use , Tomography, X-Ray Computed
SELECTION OF CITATIONS
SEARCH DETAIL
...